A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
A gene, ATM , that is mutated in the autosomal recessive disorder ataxia telangiectasia (AT) was identified by positional cloning on chromosome 11q22-23. AT is characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, cancer predisposition, radiation sensitivity, and cell cycle abnormalities. The disease is genetically heterogeneous, with four complementation groups that have been suspected to represent different genes. ATM , which has a transcript of 12 kilobases, was found to be mutated in AT patients from all complementation groups, indicating that it is probably the sole gene responsible for this disorder. A partial ATM complementary DNA clone of 5.9 kilobases encoded a putative protein that is similar to several yeast and mammalian phosphatidylinositol-3′ kinases that are involved in mitogenic signal transduction, meiotic recombination, and cell cycle control. The discovery of ATM should enhance understanding of AT and related syndromes and may allow the identification of AT heterozygotes, who are at increased risk of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [49]
Citations
Cites
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Requirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth Factor
Yao, R., & Cooper, G. M. (1995) · Science · doi:10.1126/science.7701324 · Cited by 1,391
A workbench for multiple alignment construction and analysis
Schuler, G. D., Altschul, S. F., & Lipman, D. J. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340090304 · Cited by 985
Incidence of Cancer in 161 Families Affected by Ataxia–Telangiectasia
Swift, M., Morrell, D., Massey, R. B., & Chase, C. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252602 · Cited by 939
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Kunz, J., Henriquez, R., Schneider, U., Deuter-Reinhard, M., Movva, N. R., & Hall, M. N. (1993) · Cell · doi:10.1016/0092-8674(93)90144-f · Cited by 834
Radiosensitivity in ataxia-telangiectasia: a new explanation.
Painter, R. B., & Young, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7315 · Cited by 789
Phosphatidylinositol 3-Kinase Encoded by Yeast VPS 34 Gene Essential for Protein Sorting
Schu, P. V., Takegawa, K., Fry, M. J., Stack, J. H., Waterfield, M. D., & Emr, S. D. (1993) · Science · doi:10.1126/science.8385367 · Cited by 778
Research works printed but not linked: 12
- Green, M. H. L., Journal of Cell Science 6: 127 (1987).
- Lange, E., American Journal of Human Genetics 57: 112 (1995).
- Lavin, M. F., Ataxia-Telangiectasia: 235 (1993).
- MCCONVILLE, C.M., GENETIC AND PHYSICAL MAPPING OF THE ATAXIA-TELANGIECTASIA LOCUS ON CHROMOSOME 11Q22-Q23, INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 66: S45 (1994).
- Meyn, M. S., American Journal of Human Genetics 55 Suppl.: A3 (1994).
- OSKATO, R, AMERICAN JOURNAL OF HUMAN GENETICS 53: A1055 (1993).
- Sedgwick, R. P., Handbook of Clinical Neurology 16: 347 (1991).
- Shiloh, Y., American Journal of Human Genetics 55 Suppl.: A49 (1994).
- Shiloh, Y., Ataxia-Telangiectasia: Genetics Neuropathology and Immunology of a Degenerative Disease of Childhood: 111 (1985).
- Shiloh Y. European Journal of Human Genetics in press.
- Uhrhammer, N., American Journal of Human Genetics 57: 103 (1995).
- ZAMPETTIBOSSELE.F, INT J RADIAT BIOL 39: 547 (1981).
Cited by
Items 301–400 of 1,009
EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia
Li, J., Hart, R. P., Mallimo, E. M., Swerdel, M. R., Kusnecov, A. W., & Herrup, K. (2013) · Nature Neuroscience · doi:10.1038/nn.3564 · Cited by 176
Pathology of hereditary breast cancer
van der Groep, P., van der Wall, E., & van Diest, P. J. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0010-3 · Cited by 177
Camacho, E., Hernández, L., Hernández, S., Tort, F., Bellosillo, B., Beà, S., Bosch, F., Montserrat, E., Cardesa, A., Fernández, P. L., et al. (2002) · Blood · doi:10.1182/blood.v99.1.238 · Cited by 177
Costanzo, V., Robertson, K., Ying, C. Y., Kim, E., Avvedimento, E., Gottesman, M., Grieco, D., & Gautier, J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00063-0 · Cited by 177
“Central to this network is the ATM protein, the product of the gene mutated in the human disease ataxia-telangiectasia (Savitsky et al., 1995).”
BackgroundThe ATM protein is required for sustained activation of NF-κB following DNA damage
Piret, B., Schoonbroodt, S., & Piette, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202541 · Cited by 176
“All AT patients seem to exhibit mutations in the ATM (Ataxia Telangiectasia Mutated) gene (Gilad et al., 1996; Savitsky et al., 1995; Wright et al., 1996), and mice with a knock-out of the ATM gene show a phenotype that recapitulates the AT syndrome (Xu and Baltimore, 1996).”
Ataxia‐telangiectasia, cancer and the pathobiology of the ATM gene
Meyn, M. S. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.550501.x · Cited by 176
Verhagen, M. M. M., Last, J. I., Hogervorst, F. B. L., Smeets, D. F. C. M., Roeleveld, N., Verheijen, F., Catsman-Berrevoets, C. E., Wulffraat, N. M., Cobben, J. M., Hiel, J., et al. (2012) · Human Mutation · doi:10.1002/humu.22016 · Cited by 174
“The ATM gene is localized on chromosome 11q22-23 and contains 66 exons [Gatti et al., 1988; Savitsky et al., 1995].”
BackgroundSelf-citationClinical spectrum of ataxia-telangiectasia in adulthood
Verhagen, M. M. M., Abdo, W. F., Willemsen, M. A. A. P., Hogervorst, F. B. L., Smeets, D. F. C. M., Hiel, J. A. P., Brunt, E. R., van Rijn, M. A., Majoor Krakauer, D., Oldenburg, R. A., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181af33bd · Cited by 174
Self-citationChanges in protein composition of meiotic nodules during mammalian meiosis
Plug, A. W., Peters, A. H. F. M., Keegan, K. S., Hoekstra, M. F., Boer, P. D., & Ashley, T. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.4.413 · Cited by 175
Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs
Toledo, L. I., Murga, M., & Fernandez‐Capetillo, O. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.002 · Cited by 175
“…of Chk1 and a full activation of the RSR. Pioneering work from Yossi Shiloh and colleagues led to the identification of a kinase that was responsible for the radiosensitivity observed in patients of a rare hereditary disease known as Ataxia Telangiectasia (AT) (Savitsky et al., 1995).”
BackgroundElevated Oxidative Stress in Patients with Ataxia Telangiectasia
Reichenbach, J., Schubert, R., Schindler, D., Müller, K., Böhles, H., & Zielen, S. (2002) · Antioxidants & Redox Signaling · doi:10.1089/15230860260196254 · Cited by 173
“The gene responsible for the pleiotropic phenotype of the disease, ATM (AT-mutated), is a member of a family of large proteins that have a phosphatidylinositol 3-kinase catalytic domain at the C-terminus (33).”
A Quantitative Measurement of the Human Somatic Mutation Rate
Araten, D. J., Golde, D. W., Zhang, R. H., Thaler, H. T., Gargiulo, L., Notaro, R., & Luzzatto, L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1198 · Cited by 173
“We next analyzed AT1ABR, derived from a patient with ataxia-telangiectasia, who is homozygous for the ATM 7636 del 9 mutation (22); here the frequency of GPI cells was 50 10 (6).”
MethodPurification and DNA binding properties of the ataxia-telangiectasia gene product ATM
Smith, G. C. M., Cary, R. B., Lakin, N. D., Hann, B. C., Teo, S.-H., Chen, D. J., & Jackson, S. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11134 · Cited by 173
Cristini, A., Ricci, G., Britton, S., Salimbeni, S., Huang, S.-Y. N., Marinello, J., Calsou, P., Pommier, Y., Favre, G., Capranico, G., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.041 · Cited by 172
“, 2014), can also cause neurological diseases (Kannan et al., 2018; Savitsky et al., 1995).”
BackgroundDNA damage response pathway in radioadaptive response
Sasaki, M. S., Ejima, Y., Tachibana, A., Yamada, T., Ishizaki, K., Shimizu, T., & Nomura, T. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00084-2 · Cited by 171
Blakely, E. A., & Kronenberg, A. (1998) · Radiation Research · doi:10.2307/3579815 · Cited by 171
Biology and treatment of childhood T-lineage acute lymphoblastic leukemia.
Uckun, F. M., Sensel, M. G., Sun, L., Steinherz, P. G., Trigg, M. E., Heerema, N. A., Sather, H. N., Reaman, G. H., & Gaynon, P. S. (1998) · PubMed · doi:10.1182/blood.v91.3.735 · Cited by 171
Chromosome instability syndromes
Taylor, A. M. R. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2001.0158 · Cited by 170
Self-citationCellular radiosensitivity: How much better do we understand it?
Jeggo, P., & Lavin, M. F. (2009) · International Journal of Radiation Biology · doi:10.3109/09553000903261263 · Cited by 168
“Via an amazing tour de force in positional cloning, ATM was identified as the gene defective in A-T patients, a particularly difficult challenge due to the large size of the gene (Savitsky et al. 1995).”
Self-citationArai, Y., Hosoda, F., Kobayashi, H., Arai, K., Hayashi, Y., Kamada, N., Kaneko, Y., & Ohki, M. (1997) · Blood · doi:10.1182/blood.v89.11.3936 · Cited by 171
Inactivation of the ATM Gene in T-Cell Prolymphocytic Leukemias
Stoppa-Lyonnet, D., Soulier, J., Laugé, A., Dastot, H., Garand, R., Sigaux, F., & Stern, M.-H. (1998) · Blood · doi:10.1182/blood.v91.10.3920 · Cited by 171
Telatar, M., Teraoka, S., Wang, Z., Chun, H. H., Liang, T., Castellvi-Bel, S., Udar, N., Borresen-Dale, A.-L., Chessa, L., Bernatowska-Matuszkiewicz, E., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301673 · Cited by 170
Self-citationWang, Y. A., Elson, A., & Leder, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14590 · Cited by 170
Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation
Ali, A., Zhang, J., Bao, S., Liu, I., Otterness, D., Dean, N. M., Abraham, R. T., & Wang, X.-F. (2004) · Genes & Development · doi:10.1101/gad.1176004 · Cited by 169
“Biallelic loss-of-function mutations in the human ATM gene give rise to ataxia telangiectasia (A-T), an autosomal recessive disease characterized by neuronal and immune dysfunction, cancer predisposition, and premature aging (Savitsky et al. 1995).”
BackgroundNbs1 is required for ATR‐dependent phosphorylation events
Stiff, T., Reis, C., Alderton, G. K., Woodbine, L., O'Driscoll, M., & Jeggo, P. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600504 · Cited by 169
“ATR, like ATM, is a PIKK family member and plays a central role in a parallel damage response pathway (Bentley et al, 1996; Zou et al, 2002).”
The Inherited Basis of Human Radiosensitivity
Gatti, R. A. (2001) · Acta Oncologica · doi:10.1080/02841860152619115 · Cited by 168
Self-citationThe Secondary Leukemias: Challenges and Research Directions
Smith, M. A., McCaffrey, R. P., & Karp, J. E. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.7.407 · Cited by 170
Navas, T. A., Sanchez, Y., & Elledge, S. J. (1996) · Genes & Development · doi:10.1101/gad.10.20.2632 · Cited by 167
Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype
Micol, R., Ben Slama, L., Suarez, F., Le Mignot, L., Beauté, J., Mahlaoui, N., Dubois d’Enghien, C., Laugé, A., Hall, J., Couturier, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.03.052 · Cited by 164
Yaar, M., & Gilchrest, B. A. (2001) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(05)70089-6 · Cited by 166
Mitotic DNA damage and replication checkpoints in yeast
Rhind, N., & Russell, P. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80118-x · Cited by 166
DNA-PK: at the cross-roads of biochemistry and genetics
Jeggo, P. A. (1997) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(97)00009-8 · Cited by 166
Mortality Rates among Carriers of Ataxia-Telangiectasia Mutant Alleles
Su, Y., & Swift, M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-10-200011210-00009 · Cited by 165
“The haplotypes associated with the ataxiatelangiectasia allele in each family member were determined by analyzing three microsatellite markers on chromosome 11q near or within the ataxia-telangiectasia locus: D11S1778 (telomeric), D11S1819 (centromeric), and D11S2179 (intragenic) (12, 14, 15, 18).”
BackgroundMethodPhenotypic effects of mosaicism for a 47,XXX cell line in Turner syndrome
Sybert, V. P. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.217 · Cited by 164
Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase
Kharbanda, S., Kumar, V., Dhar, S., Pandey, P., Chen, C., Majumder, P., Yuan, Z.-M., Whang, Y., Strauss, W., Pandita, T. K., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00483-8 · Cited by 165
“The catalytic subunit of DNA-PK (DNA-PKcs) and ATM are members of a family of phosphatidylinositol (PI) 3-kinase-like enzymes involved in regulation of the cell cycle, recombination, control of telomere length and the DNA damage response [28–30].”
Contributions of ATM mutations to familial breast and ovarian cancer.
Thorstenson, Y. R., Roxas, A., Kroiss, R., Jenkins, M. A., Yu, K. M., Bachrich, T., Muhr, D., Wayne, T. L., Chu, G., Davis, R. W., et al. (2003) · PubMed · Cited by 162
The ATM-dependent DNA Damage Signaling Pathway
KITAGAWA, R., & KASTAN, M. B. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.002 · Cited by 163
“Identification of the ATM gene by Shiloh and colleagues (Savitsky et al. 1995) revealed a very large gene that coded for a protein containing a phosphoinositide 3 (PI3) kinase-like sequence in its carboxyl terminus.”
BackgroundIntrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells
Ambrose, M., Goldstine, J. V., & Gatti, R. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm166 · Cited by 163
“ATM is a high-molecular weight (350 kDa) serine/threonine kinase that is closely related to DNA-dependent protein kinase catalytic subunit (DNA-PKcs), A-T and Rad3-related protein (ATR), mammalian target of rapamycin/FKBP-rapamycin-associated protein (mTOR/FRAP) and ATX/SMG1, all of which are involved in the DNA damag…”
BackgroundSelf-citationFragments of ATM Which Have Dominant-Negative or Complementing Activity
Morgan, S. E., Lovly, C., Pandita, T. K., Shiloh, Y., & Kastan, M. B. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2020 · Cited by 162
Self-citationEng, L., Coutinho, G., Nahas, S., Yeo, G., Tanouye, R., Babaei, M., Dörk, T., Burge, C., & Gatti, R. A. (2004) · Human Mutation · doi:10.1002/humu.10295 · Cited by 160
Self-citationIdentification of a Novel Protein Kinase Mediating Akt Survival Signaling to the ATM Protein
Suzuki, A., Kusakai, G.-I., Kishimoto, A., Lu, J., Ogura, T., Lavin, M. F., & Esumi, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206025200 · Cited by 161
Self-citationBrown, K. D., Ziv, Y., Sadanandan, S. N., Chessa, L., Collins, F. S., Shiloh, Y., & Tagle, D. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1840 · Cited by 161
Self-citationResponses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family
Hoekstra, M. F. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80125-6 · Cited by 161
Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses
Martinho, R. G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7239 · Cited by 161
Hypothesis: Ataxia‐telangiectasia: Is ATM a sensor of oxidative damage and stress?
Rotman, G., & Shiloh, Y. (1997) · BioEssays · doi:10.1002/bies.950191011 · Cited by 160
Self-citationMolecular pathogenesis of pancreatic cancer
Hansel, D. E., Kern, S. E., & Hruban, R. H. (2003) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.4.070802.110341 · Cited by 159
Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia
Lavin, M. F., Gueven, N., Bottle, S., & Gatti, R. A. (2007) · British Medical Bulletin · doi:10.1093/bmb/ldm012 · Cited by 160
“…(1976),59 Huo et al. (1994),60 Sun et al. (2002)61 p53 stabilization Defective Kastan et al. (1992),62 Khanna and Lavin (1993)63 ATM mutations Yes Savitsky et al. (1995)8 ATM protein Absent/ Detectable Watters et al. (1997),64 Becker-Catania et al. (2000),65 Chun et al. (2003)66 ATM kinase…”
BackgroundSelf-citationFriedreich's ataxia protein: phylogenetic evidence for mitochondrial dysfunction
Gibson, T. J., Koonin, E. V., Musco, G., Pastore, A., & Bork, P. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)20054-2 · Cited by 159
Ataxia telangiectasia mutated is essential during adult neurogenesis
Allen, D. M., van Praag, H., Ray, J., Weaver, Z., Winrow, C. J., Carter, T. A., Braquet, R., Harrington, E., Ried, T., Brown, K. D., et al. (2001) · Genes & Development · doi:10.1101/gad.869001 · Cited by 159
Mammalian DNA topoisomerase IIIα is essential in early embryogenesis
Li, W., & Wang, J. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1010 · Cited by 158
Iannuzzi, C. M., Atencio, D. P., Green, S., Stock, R. G., & Rosenstein, B. S. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02684-0 · Cited by 163
Genome integrity and disease prevention in the nervous system
McKinnon, P. J. (2017) · Genes & Development · doi:10.1101/gad.301325.117 · Cited by 157
“Subsequently, as the genetic basis for A-T was shown to be mutation of a DNA damage-responsive kinase, ATM (Savitsky et al. 1995), it became clear that genome instability was driving pathology in this neurodegenerative syndrome.”
BackgroundCell division in the CNS: Protective response or lethal event in post-mitotic neurons?
Yang, Y., & Herrup, K. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.002 · Cited by 172
“The primary sequence shows analogy with the catalytic subunit of phosphatidyl-inositol-3-kinase (PI3K) [71-75].”
BackgroundSplitting the ATM: distinct repair and checkpoint defects in ataxia–telangiectasia
Jeggo, P. A., Carr, A. M., & Lehmann, A. R. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01511-x · Cited by 156
Phase 2 study of sodium phenylbutyrate in ALS
Cudkowicz, M. E., Andres, P. L., Macdonald, S. A., Bedlack, R. S., Choudry, R., Brown Jr, R. H., Zhang, H., Schoenfeld, D. A., Shefner, J., Matson, S., et al. (2009) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802320487 · Cited by 154
“Tolerability for NaPB in subjects with ALS was similar to that in subjects with Huntington’s disease (16), solid tumor malignancies (17), malignant gliomas (18), myelodysplastic syndromes and acute myelogenous leukemia (19), sickle cell anemia and beta thalassemias (20) where the maximum tolerated dosages of NaPB were…”
ResultDantzer, F., Nasheuer, H. P., Vonesch, J. L., de Murcia, G., & Murcia, J. M.-D. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.8.1891 · Cited by 178
Ionizing radiation activates the ATM kinase throughout the cell cycle
Pandita, T. K., Lieberman, H. B., Lim, D., Dhar, S., Zheng, W., Taya, Y., & Kastan, M. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203444 · Cited by 169
“…and its product shares the PI-3 kinase signature of a growing family of proteins involved in the control of cell cycle progression, processing of DNA damage and maintenance of genomic stability (Hawley and Friend, 1996; Keith and Schreiber, 1995; Morrow et al., 1995; Savitsky et al., 1995a,b).”
BackgroundDiverse and dynamic functions of the Sir silencing complex
Guarente, L. (1999) · Nature Genetics · doi:10.1038/15458 · Cited by 159
Reality CHEK: Understanding the biology and clinical potential of CHK1
Neizer‐Ashun, F., & Bhattacharya, R. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.09.016 · Cited by 167
Thompson, S. L., & Compton, D. A. (2010) · Chromosome Research · doi:10.1007/s10577-010-9179-y · Cited by 179
“Loss of ATM allows cells to progress through the cell cycle in the presence of double stranded breaks and greatly enhances the frequency of CSI (Savitsky et al. 1995; Lavin 2008).”
The role of DNA damage repair in aging of adult stem cells
Kenyon, J., & Gerson, S. L. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1064 · Cited by 152
Edwards, E., Geng, L., Tan, J., Onishko, H. M., Donnelly, E. F., & Hallahan, D. E. (2002) · PubMed · Cited by 171
Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest
Capasso, H., Palermo, C., Wan, S., Rao, H., John, U. P., O'Connell, M. J., & Walworth, N. C. (2002) · Journal of Cell Science · doi:10.1242/jcs.00133 · Cited by 150
“As a presumed kinase-inactive mutant of Chk1 was shown to lack this mobility shift, we initially proposed that the shift might result from autophosphorylation (Walworth and Bernards, 1996).”
BackgroundSpectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
Dörk, T., Bendix, R., Bremer, M., Rades, D., Klöpper, K., Nicke, M., Skawran, B., Hector, A., Yamini, P., Steinmann, D., et al. (2001) · PubMed · Cited by 151
Cell cycle-dependent and ATM-independent expression of human Chk1 kinase
Kaneko, Y., Watanabe, N., Morisaki, H., Akita, H., Fujimoto, A., Tominaga, K., Terasawa, M., Tachibana, A., Ikeda, K., & Nakanishi, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202706 · Cited by 169
“Of these, rad3, a yeast homolog of human ATM (ataxia telangiectasia mutated), appears to play a central role in both DNA damage and DNA replication checkpoints (Savitsky et al., 1995; Bentley et al., 1996; Cimprich et al., 1996).”
BackgroundEvans, D. G., Astley, S., Stavrinos, P., Harkness, E. F., Donnelly, L. S., Dawe, S., Jacob, I., Harvie, M., Cuzick, J. M., Brentnall, A. R., et al. (2016) · Programme Grants for Applied Research · doi:10.3310/pgfar04110 · Cited by 171
“The ATM gene was then mapped and identified by positional cloning.(112,113) ATM is a protein kinase with multiple complex functions, including a central role in DNA double-strand break repair in concert with BRCA1/BRCA2.”
BackgroundAtaxia telangiectasia gene mutations in leukaemia and lymphoma
Boultwood, J. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.7.512 · Cited by 165
The dual role model for p53 in maintaining genomic integrity
Janus, F., Albrechtsen, N. J. W., Dornreiter, I., Wiesmüller, L., Große, F., & Deppert, W. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050266 · Cited by 351
Sidorova, J. M., & Breeden, L. L. (1997) · Genes & Development · doi:10.1101/gad.11.22.3032 · Cited by 150
“MEC1 encodes a member of a PI kinase family and has homologs in fission yeast, Drosophila, mice, and humans (Al-Khodairy and Carr 1992; Hari et al. 1995; Morrow et al. 1995; Savitsky et al. 1995; Pecker et al. 1996).”
BackgroundThe interaction of genetic and environmental factors in the etiology of hypertension
Kuneš, J., & Zicha, J. (2009) · Physiological Research · doi:10.33549/physiolres.931913 · Cited by 170
A new wave of innovations within the DNA damage response
Li, Q., Qian, W., Zhang, Y., Hu, L., Chen, S., & Xia, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01548-8 · Cited by 188
Bernstein, J. L., Haile, R. W., Stovall, M., Boice, J. D., Shore, R. E., Langholz, B. M., Thomas, D. C., Bernstein, L., Lynch, C. F., Olsen, J. H., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq055 · Cited by 160
“ATM, the protein product of the ATM gene, plays a central role in sensing and signaling the presence of DNA double-strand breaks that are induced by ionizing radiation (22,25,26).”
BackgroundSelf-citationPeretz, S., Jensen, R., Baserga, R., & Glazer, P. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1676 · Cited by 145
Cortez, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307088200 · Cited by 145
Sequence Information from 42−108-mer DNAs (Complete for a 50-mer) by Tandem Mass Spectrometry
Little, D. P., Aaserud, D. J., Valaskovic, G. A., & McLafferty, F. W. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9533611 · Cited by 157
Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer
Land, C. (1995) · JAMA · doi:10.1001/jama.274.5.402 · Cited by 145
Reiman, A., Srinivasan, V., Barone, G., Last, J. I., Wootton, L. L., Davies, E. G., Verhagen, M. M. M., Willemsen, M. A. A. P., Weemaes, C. M. R., Byrd, P. J., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.266 · Cited by 144
“Almost all cases of A-T are caused by homozygous or (more commonly) compound heterozygous mutations in the ATM gene (MIM 607585) (Savitsky et al, 1995; Taylor and Byrd, 2005).”
BackgroundSelf-citationSokoloff, M. H., Tso, C.-L., Kaboo, R., Taneja, S. S., Pang, S., deKernion, J. B., & Belldegrun, A. S. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960501)77:9<1862::aid-cncr16>3.0.co;2-y · Cited by 82
DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus
Jhappan, C., Morse, H. C., Fleischmann, R. D., Gottesman, M. M., & Merlino, G. T. (1997) · Nature Genetics · doi:10.1038/ng1297-483 · Cited by 157
Defective neurogenesis resulting from DNA ligase IV deficiency requires Atm
Lee, Y., Barnes, D. E., Lindahl, T., & McKinnon, P. J. (2000) · Genes & Development · doi:10.1101/gad.837100 · Cited by 144
“In budding yeast, the small amount of residual DNA end-joining observed in cells lacking Lig4 is associated with the introduction of frequent sequence errors and misalignments (Schar et al. 1997).”
BackgroundFernet, M., Gribaa, M., Salih, M. A. M., Seidahmed, M. Z., Hall, J., & Koenig, M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi027 · Cited by 143
“Two distinct genes, encoding for proteins involved in a same pathway, are responsible for the two disorders: ATM for AT and MRE11 for ATLD (20,33).”
BackgroundTchirkov, A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.3.227 · Cited by 143
“In most cases, mutations of the ATM (for ataxia–telangiectasia mutated gene), account for this pleiotropic phenotype (2).”
BackgroundBurtelow, M. A., Roos-Mattjus, P. M. K., Rauen, M., Babendure, J. R., & Karnitz, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102946200 · Cited by 143
Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening.
Telatar, M., Wang, Z., Udar, N., Liang, T., Bernatowska, E. A., Lavin, M. F., Shiloh, Y., CONCANNON, P. J., Good, R. A., & Gatti, R. A. (1996) · PubMed Central · Cited by 143
Self-citationArsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts.
Yih, L., & Lee, T. (2000) · PubMed · Cited by 149
Onge, R. P. S., Udell, C. M., Casselman, R., & Davey, S. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.6.1985 · Cited by 141
Chromosome breakage syndromes and cancer
Duker, N. J. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10688 · Cited by 154
Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities
Sbodio, J. I., Snyder, S. H., & Paul, B. D. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7321 · Cited by 140
“Ataxia telangiectasia is characterized by an unsteady gait (ataxia) and dilation of blood vessels (telangiectases) in the conjunctiva of the eyes or facial skin (449).”
BackgroundCrawford, T. O. (1998) · Seminars in Pediatric Neurology · doi:10.1016/s1071-9091(98)80007-7 · Cited by 140
ATM and RPA in meiotic chromosome synapsis and recombination
Plug, A. W., Peters, A. H. F. M., Xu, Y., Keegan, K. S., Hoekstra, M. F., Baltimore, D., de Boer, P., & Ashley, T. (1997) · Nature Genetics · doi:10.1038/ng1297-457 · Cited by 156
Petersen, A. J., Rimkus, S. A., & Wassarman, D. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110470109 · Cited by 139
“A-T is caused by mutation of the A-T mutated (ATM) gene, which encodes a serine/threonine protein kinase of the PI3K-related kinase (PIKK) family (4).”
BackgroundCancer chemoprevention by the antioxidant tempol in Atm-deficient mice
Schubert, R. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh189 · Cited by 139
“AT results from mutations in the ATM kinase, a member of a family that includes P-I3 and DNA-PKcs kinase (11,12).”
BackgroundThe ATR barrier to replication-born DNA damage
López-Contreras, A. J., & Fernandez-Capetillo, O. (2010) · DNA Repair · doi:10.1016/j.dnarep.2010.09.012 · Cited by 139
Consequences of the Delayed Diagnosis of Ataxia-Telangiectasia
Cabana, M. D., Crawford, T. O., Winkelstein, J. A., Christensen, J. R., & Lederman, H. M. (1998) · Pediatrics · doi:10.1542/peds.102.1.98 · Cited by 139
Norman, R. A., Thompson, D. B., Foroud, T., Garvey, W. T., Bennett, P. H., Bogardus, C., & Ravussin, É. (1997) · PubMed · Cited by 138
Cuddihy, A. R., Li, S., Tam, N. W. N., Wong, A. H.-T., Taya, Y., Abraham, N., Bell, J. C., & Koromilas, A. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2475 · Cited by 137
“One is the ATM protein, a PI-3 like kinase (62) which activates p53 in response to g radiation (6, 76).”
BackgroundMyung, K., Pennaneach, V., Kats, E. S., & Kolodner, R. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232239100 · Cited by 137
Neurodegeneration Is Associated to Changes in Serum Insulin-like Growth Factors
Busiguina, S., Fernandez, A. M., Barrios, V., Clark, R., Tolbert, D. L., Berciano, J., & Torres-Aleman, I. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0311 · Cited by 137
F. Lavin, K. K. K. (1999) · International Journal of Radiation Biology · doi:10.1080/095530099139359 · Cited by 136
Self-citationDefect in Multiple Cell Cycle Checkpoints in Ataxia-Telangiectasia Postirradiation
Beamish, H., Williams, R., Chen, P., & Lavin, M. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20486 · Cited by 137
Self-citation
Metadata
- Authors
- Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S., & Shiloh, Y.
- Affiliations
- Tel Aviv University (IL)
- Department of Human Genetics, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
- National Institutes of Health (US)
- Sheba Medical Center (IL)
- Yale University (US)
- The University of Texas Southwestern Medical Center (US)
- University of California, Los Angeles (US)
- Sapienza University of Rome (IT)
- Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
- QIMR Berghofer Medical Research Institute (AU)
- Erasmus University Rotterdam (NL)
- University of Birmingham (GB)
- University of Sussex (GB)
- ORCID
- Venue
- Science
- Published
- 1995-06-23
- Volume
- 268
- Issue
- 5218
- Pages
- 1749-1753
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2159168998
- Cited by
- 2,785
- References
- 54
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 45 · 2023: 34 · 2022: 43 · 2021: 73 · 2020: 60 · 2019: 61 · 2018: 53 · 2017: 67 · 2016: 59 · 2015: 69 · 2014: 80 · 2013: 75 · 2012: 87
- FWCI
- 70.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hg000882-02)
- National Human Genome Research Institute (HG00882)
- National Institute of Neurological Disorders and Stroke (R01NS031763, NS 31763)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- ataxia telangiectasia, ATM gene, phosphatidylinositol 3-kinase, positional cloning, complementation groups, cerebellar degeneration, immunodeficiency, chromosomal instability, cancer susceptibility, radiosensitivity, cell cycle regulation, mitogenic signaling, meiotic recombination
- MeSH terms
- Amino Acid Sequence, Ataxia Telangiectasia, Cell Cycle, Chromosome Mapping, Chromosomes, Human, Pair 11, Cloning, Molecular, DNA-Binding Proteins, Female, Genetic Complementation Test, Heterozygote, Humans, Male, Meiosis, Molecular Sequence Data, Neoplasms, Nucleic Acid Hybridization, Proteins, Radiation Tolerance, Signal Transduction, Protein Serine-Threonine Kinases, Sequence Deletion, Phosphotransferases (Alcohol Group Acceptor), DNA, Complementary, Chromosomes, Artificial, Yeast, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Genetic Predisposition to Disease, Tumor Suppressor Proteins, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.